BSG and neoplasm: The high expression of this receptor in OSCC, the cell membrane location, the biological role on tumor growth, invasion, dissemination, and the influence in the patient's prognosis make EMMPRIN a strong candidate for a potential molecular target for monoclonal therapies against this receptor in OSCC.